ORBIMED ADVISORS LLC Q4 2024 Filing
Filed February 14, 2025
Portfolio Value
$4.9T
Holdings
112
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (112 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | TNGXTANGO THERAPEUTICS INC | 550,000 | $1.7B | 0.03% | |
| 102 | —TURNSTONE BIOLOGICS CORP | 3,099,265 | $1.5B | 0.03% | |
| 103 | AMLXAMYLYX PHARMACEUTICALS INC | 348,000 | $1.3B | 0.03% | |
| 104 | PHGEBIOMX INC | 1,787,767 | $1.3B | 0.03% | |
| 105 | KZRKEZAR LIFE SCIENCES INC | 192,700 | $1.3B | 0.03% | |
| 106 | KRROKORRO BIO INC | 32,400 | $1.2B | 0.03% | |
| 107 | ANROALTO NEUROSCIENCE INC | 250,000 | $1.1B | 0.02% | |
| 108 | NXTCNEXTCURE INC | 1,141,200 | $879.9M | 0.02% | |
| 109 | AGIOAGIOS PHARMACEUTICALS INC | 26,700 | $877.4M | 0.02% | |
| 110 | —ELEVATION ONCOLOGY INC | 941,275 | $529.6M | 0.01% | |
| 111 | IVVDINVIVYD INC | 1,149,300 | $509.3M | 0.01% | |
| 112 | —LAKESHORE BIOPHARMA CO LTD | 140,428 | $485.9M | 0.01% | |
| 113 | XERSXERIS BIOPHARMA HOLDINGS INC | 80,420 | $272.6M | 0.01% |
PreviousPage 2 of 2